Published in AIDS Weekly, June 12th, 1995
The debate over vaccinating HIV-infected persons against pneumococcal infection continues to rage, with no consensus existing in the United Kingdom or the United States regarding the efficacy of the measure.
Prompted by several trials demonstrating vaccine protective efficacy in large numbers of patients, the American Immunization Practices Advisory Committee has recommended that HIV-positive children of two-years and over and adults with symptomatic or asymptomatic HIV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.